1977030D.AX

Novotech Selected as Scrip Awards Finalist for Best Full-Service CRO

Retrieved on: 
星期五, 十月 7, 2022
Cros, Cell, Drug development, Gene, Research, Investment, Technology, Best, Award, AU, Ownership, CRO, Fine chemical, Asia-Pacific

SYDNEY, AU, Oct 7, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO, joins a prestigious group of global CROs as a finalist in the Scrip Award for Best Full-Service CRO.

Key Points: 
  • SYDNEY, AU, Oct 7, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO, joins a prestigious group of global CROs as a finalist in the Scrip Award for Best Full-Service CRO.
  • According to the Scrip Award organizers: "The Award for the Best CRO acknowledges the critical role that CROs play in drug development.
  • Novotech CEO Dr. John Moller said he was extremely pleased that Novotech has been selected as a finalist and thanked the global Novotech team for their hard work and commitment to a truly customer focused approach to accelerate clinical development.
  • Novotech has recently been benchmarked as a top 10 CRO among the world's leading CROs and has also been selected for the Gene & Cell Therapy Excellence Award.

Novotech Presented with Cell & Gene Excellence Award 2022 at 6th Cell & Gene Therapy World Asia Conference

Retrieved on: 
星期四, 九月 15, 2022
ROW, Tumors of the hematopoietic and lymphoid tissues, Lymphoma, News, NHL, OF, Cros, Degenerative disease, Investment, Ownership, UNIVERSAL, Technology, Cell, CRO, Liver, Drug development, CELL, Research, AU, ALL, Patent, DLBCL, Fine chemical, Vaccine, Asia-Pacific

SYDNEY, AU, Sept 15, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Cell & Gene Therapy Clinical Trials award at the 6th Cell & Gene Therapy World Asia 2022 conference.

Key Points: 
  • SYDNEY, AU, Sept 15, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Cell & Gene Therapy Clinical Trials award at the 6th Cell & Gene Therapy World Asia 2022 conference.
  • The Asia Pacific accounts for over a third of cell & gene therapy trial activity with China being the leading location in APAC.
  • Watch our recent Endpoints News webinar for more information:
    EVOLUTION OF CELL & GENE THERAPY IN CHINA: THE CASE FOR UNIVERSAL CAR-T
    The award was presented to Novotech during the 6th Cell & Gene Therapy World Asia 2022 conference (14th - 15th September) at the Sheraton Towers, Singapore.
  • Novotech CEO Dr. John Moller said we are extremely pleased our team has been recognized with this prestigious award at the 6th Cell & Gene Therapy World Asia 2022 conference.